Clinical Trial Update: Efficacy of Ethyl Icosapentate in Patients With Severe Hypertriglyceridemia [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the efficacy of Ethyl Icosapentate in adults with severe hypertriglyceridemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertriglyceridemia

Drugs mentioned

• Ethyl Icosapentate (ethyl icosapentate)

Snippet

Sponsor: Mochida Pharmaceutical Company, Ltd. | Conditions: Hypertriglyceridemia | Phase 3 | Status: COMPLETED